Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on August 13, 2025.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics' board met on August 13, 2025 and approved unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations fell sharply to ₹20.01 crore from ₹30.84 crore in the same quarter last year, a drop of about 35%. The company reported a net loss of ₹21.12 crore, much wider than the ₹2.73 crore loss in Q1 FY25, with a loss per share of ₹4.22. A major fire on May 18, 2025 at the company's main (mother) factory in Ratnagiri, Maharashtra brought all production to a halt, and because the assets were not insured, the company booked an exceptional loss of ₹20.57 crore covering destroyed inventories (₹12.74 crore), property and equipment (₹7 crore provisional), and other expenses. The auditor flagged a going concern issue as the company cannot restart manufacturing due to pending clearances and is exploring contract manufacturing or leasing options to resume operations.
This is significantly negative for shareholders: revenue collapsed, losses deepened sharply, the core factory is non-operational, and there is no insurance recovery to offset the loss. The going concern qualification and uncertain restart timeline add further risk and could weigh heavily on the stock price.